Evidence map›Paper›PMID 32095077›Full record

ArticleOncoTargets and therapy2020

A Rare Case of Moderately Differentiated Adenocarcinoma With PD-L1 Overexpression and a Heterogeneous LELC Component in the Ascending Colon.

Hideki Nagano, Takeshi Watanabe, Tamotsu Togawa, Kenji Ohnishi, Toshihisa Kimura, Atsushi Iida, Yasunori Sato, Takanori Goi

Open access · goldAbstract readCase Reports
In one paragraph

Article in OncoTargets and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Hideki NaganoDepartment of Surgery, National Hospital Organization Tsuruga Medical Center, Fukui 914-0195, Japan.
Takeshi WatanabeDepartment of Surgery, National Hospital Organization Tsuruga Medical Center, Fukui 914-0195, Japan.
Tamotsu TogawaDepartment of Surgery, National Hospital Organization Tsuruga Medical Center, Fukui 914-0195, Japan.ORCID 0000-0002-4267-6186
Kenji OhnishiDepartment of Surgery, National Hospital Organization Tsuruga Medical Center, Fukui 914-0195, Japan.
Toshihisa KimuraDepartment of Surgery, National Hospital Organization Tsuruga Medical Center, Fukui 914-0195, Japan.
Atsushi IidaDepartment of Surgery, National Hospital Organization Tsuruga Medical Center, Fukui 914-0195, Japan.ORCID 0000-0001-8771-4388
Yasunori SatoDepartment of Human Pathology, Kanazawa University, Graduate School of Medicine, Kanazawa 920-8640, Japan.
Takanori GoiFirst Department of Surgery, Faculty of Medicine, University of Fukui, Fukui 910-1193, Japan.
Municipal Tsuruga Hospital · JPKanazawa University · JPUniversity of Fukui · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLymphoepithelioma-like carcinomas (LELCs), especially colorectal cancers (CRCs), are uncommon pathological phenotypes generally associated with poor aggressiveness and a preferable prognosis. However, PD-L1 overexpression in CRCs is associated with poor outcomes. We report a case of moderately differentiated adenocarcinoma with PD-L1 overexpression, an LELC component, and Crohn's-like lymphoid reaction (CLR) presenting with extreme locoregional aggression and complete remission with chemotherapy after noncurative excision. CASE PRESENTATION: A 69-year-old man was referred to our hospital for abdominal fullness and pain. Computed tomography (CT) showed a circumferential tumor in the ascending colon, accompanied by bulky swollen lymph nodes. Under the preoperative diagnosis of T4N2M1 (lymph nodes) ascending colon cancer, we performed a right hemicolectomy; however, paracaval and parailiac vein lymph nodes were abandoned. Pathological findings showed moderate to poorly differentiated adenocarcinoma invading the subserosa accompanied by an LELC component invading the superficial muscularis propria. Lymph node metastases were found in a neighboring tumor and in retroperitoneal lymph nodes with glandular differentiation. No relation to microsatellite instability (MSI) or Epstein-Barr virus (EBV) was observed. In the component with glandular differentiation, PD-L1 overexpression was revealed. CLR findings were also observed. The tumor was diagnosed as T3N2M1 cancer that was moderately to poorly differentiated and had an LELC component. The patient was treated with chemotherapy, and the metastasized lymph nodes ultimately disappeared. He was alive without tumor recurrence 5-years post-operation.

conclusionThis is a very rare case of moderately differentiated adenocarcinoma with PD-L1 overexpression and a heterogeneous LELC component that developed in the ascending colon. Unlike the previously reported weak aggressive properties of LELCs, the present case showed an extremely aggressive locoregional extent, but complete remission was finally achieved with chemotherapy. This type of LELC with CLR could be associated with a good response to chemotherapy and a good prognosis in CRC patients.

Indexed as

adenocarcinomacolonCrohn’s-like lymphoid reactionlymphoepithelioma-like carcinomalymphoid stromaPD-L1

Identifiers

PMID32095077
PMCPMC6995307
OpenAlexW3002370770

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.